What Is Manganese? Normal vs Optimal Range Explained

The standard lab range for blood manganese extends from 0.4 to 1.1 ng/mL, but this range conceals risk at both ends. At 0.4 ng/mL, manganese-dependent enzymes—particularly SOD2, your mitochondria's primary antioxidant defense—operate below optimal capacity, leaving cells more vulnerable to oxidative damage. The CTD maps over 3,100 gene–chemical interactions for manganese, reflecting its involvement in bone mineralization, cartilage synthesis, glucose regulation, and antioxidant defense. At the upper end, values approaching 1.0–1.1 ng/mL signal accumulation that can gradually damage the basal ganglia, producing neurological symptoms resembling Parkinson's disease. This dual-risk profile makes manganese unusual among minerals—while most biomarkers primarily concern deficiency, manganese demands attention in both directions.

Manganese toxicity, called manganism, historically affected welders and miners exposed to airborne manganese dust, but modern cases increasingly involve contaminated drinking water, liver disease that impairs clearance, and long-term total parenteral nutrition where manganese accumulates without the gut's natural absorption limits. The FAERS database records over 1,200 adverse event reports involving manganese-related neurotoxicity, underscoring that this is not exclusively an occupational concern. The liver normally clears excess manganese through bile, so any condition that impairs hepatic function—cirrhosis, hepatitis, bile duct obstruction—dramatically increases accumulation risk. Blood manganese above 0.9 ng/mL in someone with liver disease warrants immediate evaluation for neurological symptoms.

Targeting the 0.5–0.9 ng/mL optimal range ensures adequate cofactor supply for SOD2 and bone-forming enzymes while staying well below the neurotoxic threshold. PubMed indexes over 4,500 publications on manganese neurotoxicity in humans, consistently identifying the globus pallidus as the brain region most vulnerable to manganese accumulation. Dietary manganese deficiency is rare because whole grains, nuts, tea, and leafy greens supply adequate amounts, but iron status critically influences manganese absorption—iron and manganese share the DMT1 intestinal transporter, meaning iron deficiency dramatically increases manganese uptake. This relationship makes checking manganese alongside iron particularly important in menstruating women and vegetarians who may have low iron stores.

“Manganese-induced parkinsonism shares clinical features with idiopathic Parkinson's disease but involves distinct basal ganglia pathology, preferentially targeting the globus pallidus rather than the substantia nigra.”

— Khindri et al., Degenerative Neurological and Neuromuscular Disease (2025)